Работы, цитирующие эту работу

Работ: 4

Работа: Targeting non-coding RNAs to overcome cancer therapy resistance

1. Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease

   Vivek Panwar, Aishwarya Singh, Manini Bhatt +6

   Обзорная статьяPI3K/AKT/mTOR signaling in cancerSignal Transduction and Targeted Therapy2023Цитирований: 1

   ABIABI:AkademIndex/openalex/2023.review-article.000001

2. Exploring the modulation of TLR4 and its associated ncRNAs in cancer immunopathogenesis, with an emphasis on the therapeutic implications and mechanisms underlying drug resistance

   Mohammad Y. Alshahrani, Enwa Felix Oghenemaro, Jasur Rizaev +7

   Обзорная статьяImmune Response and InflammationHuman Immunology2024Цитирований: 0

   ABIABI:AkademIndex/openalex/2024.review-article.000067

3. Non-coding RNAs at the intersection of interferon signaling and cancer: mechanistic insights and clinical prospects

   Usamah Sayed, Waleed K. Abdulsahib, S. Renuka Jyothi +6

   СтатьяCancer-related molecular mechanisms researchCancer Treatment and Research Communications2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.005222

4. Disrupting immune silence: Noncoding RNAs targeting the programmed cell death protein 1/programmed cell death ligand 1 axis in tumor immunity

   Chou-Yi Hsu, Ahmed Hjazi, Muath Suliman +7

   СтатьяCancer Immunotherapy and BiomarkersJournal of Pharmacology and Experimental Therapeutics2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.005985